Pediatric chemo regimen cuts mortality in ALL patients under 40

04/23/2012 | PhysiciansBriefing.com

Israeli researchers reported in the American Journal of Hematology that teens and young adults with acute lymphoblastic leukemia who were given pediatric-inspired induction chemotherapy drugs had lower all-cause mortality and relapse rates than the group receiving traditional adult chemotherapy regimens. They also found that the pediatric-inspired chemotherapy group had greater remission and event-free survival rates compared with the other group.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC